A novel role for the tumor suppressor gene itf2 in tumorigenesis and chemotherapy response - Pernía O; Sastre-Perona A; Rodriguez-Antolín C; García-Guede A; Palomares-Bralo M; Rosas R; Sanchez-Cabrero D; Cruz P; Rodriguez C; Diestro M; Martín-Arenas R; Pulido V; et al. (Cancers, 2020)

Signalling through the yeast MAPK Cell Wall Integrity pathway controls P-body assembly upon cell wall stress (vol 9, 3186, 2019) - Garcia, R; Pulido, V; Orellana-Munoz, S; Nombela, C; de Aldana, CRV; Rodriguez-Pena, JM; Arroyo, J (Scientific Reports, 2019)

Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy - Pernía O; Belda-Iniesta C; Pulido V; Cortes-Sempere M; Rodriguez C; Vera O; Soto J; Jiménez J; Taus A; Rojo F; Arriola E; Rovira A; et al. (Epigenetics, 2014)

Clinical and Molecular Analysis in Families With Autosomal Recessive Osteogenesis Imperfecta Identifies Mutations in Five Genes and Suggests Genotype-Phenotype Correlations - Caparros-Martin, JA; Valencia, M; Pulido, V; Martinez-Glez, V; Rueda-Arenas, I; Amr, K; Farra, C; Lapunzina, P; Ruiz-Perez, VL; Temtamy, S; Aglan, M (American Journal Of Medical Genetics Part a, 2013)

Mutations in PLOD2 Cause Autosomal-Recessive Connective Tissue Disorders Within the Bruck Syndrome-Osteogenesis Imperfecta Phenotypic Spectrum - Puig-Hervas, MT; Temtamy, S; Aglan, M; Valencia, M; Martinez-Glez, V; Ballesta-Martinez, MJ; Lopez-Gonzalez, V; Ashour, AM; Amr, K; Pulido, V; Guillen-Navarro, E; Lapunzina, P; et al. (Human Mutation, 2012)

Identification of a Mutation Causing Deficient BMP1/mTLD Proteolytic Activity in Autosomal Recessive Osteogenesis Imperfecta - Martinez-Glez, V; Valencia, M; Caparros-Martin, JA; Aglan, M; Temtamy, S; Tenorio, J; Pulido, V; Lindert, U; Rohrbach, M; Eyre, D; Giunta, C; Lapunzina, P; et al. (Human Mutation, 2012)